Titulo:
Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry
.
Sumario:
Background: An estimated 43,390 breast augmentation surgeries (86,780 implants) and 1486 breast implant reconstructions are performed annually in Colombia, representing the second-most breast surgery destination in South America, the fourth in the western hemisphere, and the fifth country worldwide. No previous reports have evaluated the incidence of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) epidemiology or outcomes in a Hispanic population. Published data on the incidence of this disease in Colombia are unknown; therefore, a National Joint Multidisciplinary Committee was developed between the Colombian scientific societies of Mastology, Plastic Surgery, Hemato-Oncology, and the Invima (The National Food and Drug S... Ver más
Guardado en:
2256-2877
2256-2915
8
2022-09-21
211
212
http://purl.org/coar/access_right/c_abf2
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Carlos Andrés Ossa Gomez - 2022
info:eu-repo/semantics/openAccess
| id |
metarevistapublica_acho_revistacolombianadehematologiayoncologia_27-article-489 |
|---|---|
| record_format |
ojs |
| spelling |
Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry Breast lymphoma Bogotá: Asociación Colombiana de Hematología y Oncología, 2012- Artículo de revista Núm. Supl , Año 2021 : Suplemento 1 Supl 8 Lymphoma Breast Implants BIA-ALCL Revista colombiana de hematología y oncología Echeverri, Carolina Caicedo Mallarino, José Joaquín Background: An estimated 43,390 breast augmentation surgeries (86,780 implants) and 1486 breast implant reconstructions are performed annually in Colombia, representing the second-most breast surgery destination in South America, the fourth in the western hemisphere, and the fifth country worldwide. No previous reports have evaluated the incidence of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) epidemiology or outcomes in a Hispanic population. Published data on the incidence of this disease in Colombia are unknown; therefore, a National Joint Multidisciplinary Committee was developed between the Colombian scientific societies of Mastology, Plastic Surgery, Hemato-Oncology, and the Invima (The National Food and Drug Surveillance Institute) to track national cases of BIA-ALCL. Materials and Methods: We performed a retrospective review (survey-based study) of historical cases since 2011–2019, and a prospective collection of all patients with a confirmed World Health Organization diagnosis of BIA-ALCL identified in a newly established National Registry of BIA-ALCL. The trial was approved by Institutional Review Board (IRB). Ossa Gomez, Carlos Andrés Duque, Alejandro Fidalgo, Ana Maria Rivas Taffur, Giovanna Huertas Motta, Ramiro Mantilla Duran, William Armando Abello Polo, Virginia https://revista.acho.info/index.php/acho/article/view/489 http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 Text info:eu-repo/semantics/article Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. Carlos Andrés Ossa Gomez - 2022 https://creativecommons.org/licenses/by-nc-sa/4.0 Inglés info:eu-repo/semantics/openAccess http://purl.org/coar/resource_type/c_6501 Journal article Publication Linfoma anaplásico de células grandes asociado a implantes mamarios en Colombia: informe de un registro nacional multidisciplinario Antecedentes: Se estima que en Colombia se realizan anualmente 43.390 cirugías de aumento mamario (86.780 implantes) y 1.486 reconstrucciones con implantes mamarios, lo que representa el segundo destino de cirugía mamaria en América del Sur, el cuarto en el hemisferio occidental y el quinto país a nivel mundial. Ningún informe previo ha evaluado la incidencia de la epidemiología o los resultados del linfoma anaplásico de células grandes asociado a implantes mamarios (BIA-ALCL) en una población hispana. Se desconocen los datos publicados sobre la incidencia de esta enfermedad en Colombia; por lo tanto, se desarrolló un Comité Multidisciplinario Conjunto Nacional entre las sociedades científicas colombianas de Mastología, Cirugía Plástica, Hemato-Oncología y el Invima (Instituto Nacional de Vigilancia de Medicamentos y Alimentos) para rastrear los casos nacionales de BIA-ALCL. Materiales y métodos: Realizamos una revisión retrospectiva (estudio basado en encuestas) de casos históricos desde 2011 a 2019, y una recopilación prospectiva de todos los pacientes con diagnóstico confirmado de BIA-ALCL según la Organización Mundial de la Salud identificados en un Registro Nacional de BIA-ALCL recientemente establecido. El ensayo fue aprobado por el Comité de Revisión Institucional (IRB). Breast lymphoma application/pdf BIA-ALCL Implants Breast Lymphoma 2256-2915 https://revista.acho.info/index.php/acho/article/download/489/463 2256-2877 211 2022-09-21T00:00:00Z 2022-09-21T00:00:00Z 2022-09-21 https://doi.org/10.51643/22562915.489 10.51643/22562915.489 212 |
| institution |
ASOCIACION COLOMBIANA DE HEMATOLOGIA Y ONCOLOGIA |
| thumbnail |
https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADEHEMATOLOGIAYONCOLOGIA/logo.png |
| country_str |
Colombia |
| collection |
Revista Colombiana de Hematología y Oncología |
| title |
Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry |
| spellingShingle |
Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry Echeverri, Carolina Caicedo Mallarino, José Joaquín Ossa Gomez, Carlos Andrés Duque, Alejandro Fidalgo, Ana Maria Rivas Taffur, Giovanna Huertas Motta, Ramiro Mantilla Duran, William Armando Abello Polo, Virginia Breast lymphoma Lymphoma Breast Implants BIA-ALCL Breast lymphoma BIA-ALCL Implants Breast Lymphoma |
| title_short |
Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry |
| title_full |
Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry |
| title_fullStr |
Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry |
| title_full_unstemmed |
Breast Implant–associated Anaplastic Large Cell Lymphoma in Colombia: Report of a Multidisciplinary National Registry |
| title_sort |
breast implant–associated anaplastic large cell lymphoma in colombia: report of a multidisciplinary national registry |
| title_eng |
Linfoma anaplásico de células grandes asociado a implantes mamarios en Colombia: informe de un registro nacional multidisciplinario |
| description |
Background: An estimated 43,390 breast augmentation surgeries (86,780 implants) and 1486 breast implant reconstructions are performed annually in Colombia, representing the second-most breast surgery destination in South America, the fourth in the western hemisphere, and the fifth country worldwide. No previous reports have evaluated the incidence of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) epidemiology or outcomes in a Hispanic population. Published data on the incidence of this disease in Colombia are unknown; therefore, a National Joint Multidisciplinary Committee was developed between the Colombian scientific societies of Mastology, Plastic Surgery, Hemato-Oncology, and the Invima (The National Food and Drug Surveillance Institute) to track national cases of BIA-ALCL. Materials and Methods: We performed a retrospective review (survey-based study) of historical cases since 2011–2019, and a prospective collection of all patients with a confirmed World Health Organization diagnosis of BIA-ALCL identified in a newly established National Registry of BIA-ALCL. The trial was approved by Institutional Review Board (IRB).
|
| description_eng |
Antecedentes: Se estima que en Colombia se realizan anualmente 43.390 cirugías de aumento mamario (86.780 implantes) y 1.486 reconstrucciones con implantes mamarios, lo que representa el segundo destino de cirugía mamaria en América del Sur, el cuarto en el hemisferio occidental y el quinto país a nivel mundial. Ningún informe previo ha evaluado la incidencia de la epidemiología o los resultados del linfoma anaplásico de células grandes asociado a implantes mamarios (BIA-ALCL) en una población hispana. Se desconocen los datos publicados sobre la incidencia de esta enfermedad en Colombia; por lo tanto, se desarrolló un Comité Multidisciplinario Conjunto Nacional entre las sociedades científicas colombianas de Mastología, Cirugía Plástica, Hemato-Oncología y el Invima (Instituto Nacional de Vigilancia de Medicamentos y Alimentos) para rastrear los casos nacionales de BIA-ALCL. Materiales y métodos: Realizamos una revisión retrospectiva (estudio basado en encuestas) de casos históricos desde 2011 a 2019, y una recopilación prospectiva de todos los pacientes con diagnóstico confirmado de BIA-ALCL según la Organización Mundial de la Salud identificados en un Registro Nacional de BIA-ALCL recientemente establecido. El ensayo fue aprobado por el Comité de Revisión Institucional (IRB).
|
| author |
Echeverri, Carolina Caicedo Mallarino, José Joaquín Ossa Gomez, Carlos Andrés Duque, Alejandro Fidalgo, Ana Maria Rivas Taffur, Giovanna Huertas Motta, Ramiro Mantilla Duran, William Armando Abello Polo, Virginia |
| author_facet |
Echeverri, Carolina Caicedo Mallarino, José Joaquín Ossa Gomez, Carlos Andrés Duque, Alejandro Fidalgo, Ana Maria Rivas Taffur, Giovanna Huertas Motta, Ramiro Mantilla Duran, William Armando Abello Polo, Virginia |
| topicspa_str_mv |
Breast lymphoma Lymphoma Breast Implants BIA-ALCL |
| topic |
Breast lymphoma Lymphoma Breast Implants BIA-ALCL Breast lymphoma BIA-ALCL Implants Breast Lymphoma |
| topic_facet |
Breast lymphoma Lymphoma Breast Implants BIA-ALCL Breast lymphoma BIA-ALCL Implants Breast Lymphoma |
| citationvolume |
8 |
| citationissue |
Supl |
| citationedition |
Núm. Supl , Año 2021 : Suplemento 1 |
| publisher |
Bogotá: Asociación Colombiana de Hematología y Oncología, 2012- |
| ispartofjournal |
Revista colombiana de hematología y oncología |
| source |
https://revista.acho.info/index.php/acho/article/view/489 |
| language |
Inglés |
| format |
Article |
| rights |
http://purl.org/coar/access_right/c_abf2 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. Carlos Andrés Ossa Gomez - 2022 https://creativecommons.org/licenses/by-nc-sa/4.0 info:eu-repo/semantics/openAccess |
| type_driver |
info:eu-repo/semantics/article |
| type_coar |
http://purl.org/coar/resource_type/c_6501 |
| type_version |
info:eu-repo/semantics/publishedVersion |
| type_coarversion |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| type_content |
Text |
| publishDate |
2022-09-21 |
| date_accessioned |
2022-09-21T00:00:00Z |
| date_available |
2022-09-21T00:00:00Z |
| url |
https://revista.acho.info/index.php/acho/article/view/489 |
| url_doi |
https://doi.org/10.51643/22562915.489 |
| issn |
2256-2877 |
| eissn |
2256-2915 |
| doi |
10.51643/22562915.489 |
| citationstartpage |
211 |
| citationendpage |
212 |
| url2_str_mv |
https://revista.acho.info/index.php/acho/article/download/489/463 |
| _version_ |
1817670343688454144 |